Marea Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
135 Mississippi St, San Francisco, Calif...Phone Number
(415) 766-3610Website
www.mareatx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Marea Therapeutics
Marea Therapeutics is focused on developing innovative medicines for cardioendocrine diseases. The company aims to address unmet medical needs in this specialized field through its advanced scientific research and pipeline of therapeutic solutions. Their intended clients include healthcare providers and patients affected by these conditions. Marea Therapeutics is committed to pioneering the next frontier of treatment options in the healthcare industry.Explore more
Popular SearchesMarea Therapeutics IncSIC Code 28,283NAICS Code 32,325Show moreMarea Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Marea Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Marea Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Marea Therapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Marea Therapeutics recently announced quarterly report
Check if Marea Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Marea Therapeutics has new funding data
Click to see if Marea Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Marea Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Marea Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Marea Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Marea Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Marea Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Marea Therapeutics.
Marea Therapeutics financials insights
Gather financial insights about Marea Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$190M
Marea Therapeutics Tech Stack
A closer look at the technologies used by Marea Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Executive Move
Executive Moves, Board of Directors
Open Position
Open Position
Marea Therapeutics News & Media
Marea Therapeutics Appoints Shishir Gadam, Ph.D., as Chief Technical Officer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced the appointment of Shishir Gadam, Ph.D., as chief technical officer. Dr. Gadam has extensive experience in the biotechnology industry and brings deep expertise and leadership in biologics development and manufacturing to Marea Therapeutics.Marea Therapeutics Announces Oral Presentation Related to Acromegaly Program at ENDO 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced an upcoming oral presentation related to MAR002, the company’s potential first-in-class, anti-growth hormone receptor (GHR) antibody being developed for acromegaly, at the 2025 Annual Meeting of the Endocrine Society (ENDO), being held fromMarea Therapeutics Appoints Charmi Turner as Senior Vice President, People & Culture
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced the appointment of Charmi Turner as senior vice president, people & culture. Charmi is an experienced life sciences industry human resources executive who brings deep expertise in leadership development and organizational alignment to MMarea Therapeutics Announces Publication in The Lancet of Positive Data from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that positive results from a Phase 2a clinical trial of MAR001 were published in The Lancet entitled “Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies.” The
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Marea Therapeutics
Sign Up For FreeTo access detailed company insights
Marea Therapeutics is focused on developing innovative medicines for cardioendocrine diseases. The company aims to address unmet medical needs in this specialized field through its advanced scientific research and pipeline of therapeutic solutions. Their intended clients include healthcare providers and patients affected by these conditions. Marea... Read More
